Asahi Kasei To Acquire Calliditas - Quick Facts

(RTTNews) - Asahi Kasei said it will offer the shareholders of Calliditas Therapeutics to acquire the shares of Calliditas for the purpose of making Calliditas a subsidiary of Asahi Kasei through a voluntary tender offer for Calliditas. The tender offer will also include a concurrent offer by Asahi Kasei to acquire all American Depositary Shares, each representing two shares in Calliditas.

Asahi Kasei plans to acquire Calliditas for the total equity value of approximately 11.8 billion Swedish kronor. The Board of Calliditas recommended the shareholders and holders of American Depositary Shares of Calliditas to accept the tender offer.

For More Such Health News, visit rttnews.com.